Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NEUROLIEF LTD

Home Clinical Trial Sponsors and OrganizationsNEUROLIEF LTD

NEUROLIEF LTD

14 Shenkar Arie, Herzliya, Central District, Israel

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

7

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

7

100.0%

Trial Status Distribution

Completed

5

71.4%

Terminated

1

14.3%

Withdrawn

1

14.3%

Clinical Trials

Trials sponsored by this organization (7)

Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for Preventive Treatment of Migraine

Nov 202457 participants

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)

Aug 2021124 participants

The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine

Nov 2018187 participants

Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine

Feb 201855 participants

A Randomized, Double-blind Clinical Investigation to Evaluate the Use of the Relievion™ Device in Treating Migraine.

Jul 20178 participants

Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)

May 201628 participants

Short-term Effectiveness of Transcutaneous Nerve Stimulation in Reducing Migraine Related Pain

May 201540 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials7
Approvals
News

Back to Organizations